摘要
目的:针对氟桂利嗪联合头痛宁在偏头痛治疗中的临床效用进行分析.方法:选取2019年2月-2022年3月本院收治的偏头痛患者共100例样本数据,按照双盲法对患者进行分类,每组临床样本案例50例,分别为对照组和实验组.对照组患者需要接受氟桂利嗪进行治疗,实验组患者需要在氟桂利嗪治疗的基础上,与头痛宁进行联合性应用.对两组临床治疗有效性,用药不良反应发生情况,患者头痛次数、头痛持续时间进行比较,同时对两组患者的不良情绪水平进行比较.结果:本研究比较了两组患者的临床治疗总有效性,治愈与有效人数更多的一组为实验组,
Abstract
Objective To analyze the clinical efficacy of flunarizine combined with Toutongning in the treatment of migraine. Methods: A total of 100 migraine patients from February 2019 to March 2022 in our hospital were selected,and the patients were classified according to the double-blind method. There were 50 clinical samples in each group,which were the control group and the experimental group respectively. Patients in the control group need to be treated with flunarizine,while patients in the experimental group need to be combined with Toutongning on the basis of flunarizine. The clinical treatment effectiveness,adverse drug reactions,headache times and headache duration of the two groups were compared. Meanwhile,the adverse mood levels of the two groups were compared. Results: This study compared the total effectiveness of clinical treatment between two groups of patients,and the group with more cured and effective patients was the experimental group,P＜0.05; The adverse drug reactions of the two groups were compared. The group with higher total clinical adverse drug reactions was the control group (P＜0.05). In the comparison of headache times and headache duration between the two groups,it was found that the group with more headaches was the control group,and the headache duration of the control group was significantly longer than that of the experimental group (P＜0.05). The adverse mood levels of the two groups were compared,and there was no significant difference before and after treatment (P＞0.05). However,after treatment,the lower level group was the experimental group,and there was significant difference in data between groups (P＜0.05). Conclusion: The combined application of flunarizine and Toutongning in the clinical treatment of migraine patients can not only help patients to improve their overall clinical effectiveness,but also reduce the risk of adverse reactions,the frequency and duration of headache,and effectively improve the patients'' bad mood,which is a treatment scheme with clinical application and research significance.
万方数据